Shouhui Tongbian Capsule ameliorates constipation via gut microbiota-5-HT-intestinal motility axis. 2022

Jinzhao Bai, and Yajie Cai, and Zhiyan Huang, and Yiqing Gu, and Nana Huang, and Rong Sun, and Guimin Zhang, and Runping Liu
Beijing University of Chinese Medicine, School of Materia Medica, Beijing 100029, China.

Constipation has become an epidemic enteric medical problem, accompanied with increasing long-term sequelae. Gut microbiota and serotonin (5-HT) have been believed as predominant player in the treatment of constipation. In clinical practices, Shouhui Tongbian Capsule (SHTB) was found to effectively improve constipation symptoms and promote gastrointestinal motility. However, the specific mechanism of SHTB is not clearly elucidated. Our current study aims to explore the therapeutic effects of SHTB against the development of constipation and the underlying mechanisms related to gut bacterial and 5-HT. We established loperamide hydrochloride (LH)-induced experimental constipation mouse model to evaluate the effect of SHTB. 16S RNA sequencing, fecal microbiota transplants (FMT), high performance liquid chromatograph, and molecular biological analysis were performed to investigate the potential mechanisms of SHTB. Our data demonstrated that SHTB significantly ameliorated LH-induced experimental constipation and accelerated enteric motility via promoting 5-HT biosynthesis in enterochromaffin cells and enteric neuron growth of the enteric nervous system (ENS) in both the small intestine and colon. Additionally, SHTB significantly modulated gut microbiota dysbiosis and potentially altered microbiota metabolites to enhance intestinal 5-HT production. Finally, FMT study confirmed that the effects of SHTB on 5-HT production and constipation are dependent on modulating intestinal microbiota dysbiosis. In conclusion, our current study deciphered therapeutic mechanism of SHTB in the treatment of experimental constipation from perspectives of gut microbiota-5-HT-intetinal motility axis and provides novel insights into the appropriate and safe application of SHTB in the clinic.

UI MeSH Term Description Entries
D008139 Loperamide One of the long-acting synthetic ANTIDIARRHEALS; it is not significantly absorbed from the gut, and has no effect on the adrenergic system or central nervous system, but may antagonize histamine and interfere with acetylcholine release locally. Imodium,Loperamide Hydrochloride,Loperamide Monohydrochloride,R-18553,Hydrochloride, Loperamide,Monohydrochloride, Loperamide,R 18553,R18553
D003248 Constipation Infrequent or difficult evacuation of FECES. These symptoms are associated with a variety of causes, including low DIETARY FIBER intake, emotional or nervous disturbances, systemic and structural disorders, drug-induced aggravation, and infections. Colonic Inertia,Dyschezia
D005769 Gastrointestinal Motility The motor activity of the GASTROINTESTINAL TRACT. Intestinal Motility,Gastrointestinal Motilities,Intestinal Motilities,Motilities, Gastrointestinal,Motilities, Intestinal,Motility, Gastrointestinal,Motility, Intestinal
D000069196 Gastrointestinal Microbiome All of the microbial organisms that naturally exist within the GASTROINTESTINAL TRACT. Enteric Bacteria,Gastric Microbiome,Gastrointestinal Flora,Gastrointestinal Microbial Community,Gastrointestinal Microbiota,Gastrointestinal Microflora,Gut Flora,Gut Microbiome,Gut Microbiota,Gut Microflora,Intestinal Flora,Intestinal Microbiome,Intestinal Microbiota,Intestinal Microflora,Bacteria, Enteric,Flora, Gastrointestinal,Flora, Gut,Flora, Intestinal,Gastric Microbiomes,Gastrointestinal Microbial Communities,Gastrointestinal Microbiomes,Gastrointestinal Microbiotas,Gut Microbiomes,Gut Microbiotas,Intestinal Microbiomes,Intestinal Microbiotas,Microbial Community, Gastrointestinal,Microbiome, Gastric,Microbiome, Gastrointestinal,Microbiome, Gut,Microbiome, Intestinal,Microbiota, Gastrointestinal,Microbiota, Gut,Microbiota, Intestinal,Microflora, Gastrointestinal,Microflora, Gut,Microflora, Intestinal
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012701 Serotonin A biochemical messenger and regulator, synthesized from the essential amino acid L-TRYPTOPHAN. In humans it is found primarily in the central nervous system, gastrointestinal tract, and blood platelets. Serotonin mediates several important physiological functions including neurotransmission, gastrointestinal motility, hemostasis, and cardiovascular integrity. Multiple receptor families (RECEPTORS, SEROTONIN) explain the broad physiological actions and distribution of this biochemical mediator. 5-HT,5-Hydroxytryptamine,3-(2-Aminoethyl)-1H-indol-5-ol,Enteramine,Hippophaine,Hydroxytryptamine,5 Hydroxytryptamine
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D064806 Dysbiosis Changes in quantitative and qualitative composition of MICROBIOTA. The changes may lead to altered host microbial interaction or homeostatic imbalance that can contribute to a disease state often with inflammation. Disbacteriosis,Disbiosis,Dys-symbiosis,Dysbacteriosis,Disbacterioses,Disbioses,Dys symbiosis,Dys-symbioses,Dysbacterioses,Dysbioses

Related Publications

Jinzhao Bai, and Yajie Cai, and Zhiyan Huang, and Yiqing Gu, and Nana Huang, and Rong Sun, and Guimin Zhang, and Runping Liu
November 2022, Journal of ethnopharmacology,
Jinzhao Bai, and Yajie Cai, and Zhiyan Huang, and Yiqing Gu, and Nana Huang, and Rong Sun, and Guimin Zhang, and Runping Liu
April 2024, Chinese herbal medicines,
Jinzhao Bai, and Yajie Cai, and Zhiyan Huang, and Yiqing Gu, and Nana Huang, and Rong Sun, and Guimin Zhang, and Runping Liu
January 2021, Journal of healthcare engineering,
Jinzhao Bai, and Yajie Cai, and Zhiyan Huang, and Yiqing Gu, and Nana Huang, and Rong Sun, and Guimin Zhang, and Runping Liu
January 2023, Journal of healthcare engineering,
Jinzhao Bai, and Yajie Cai, and Zhiyan Huang, and Yiqing Gu, and Nana Huang, and Rong Sun, and Guimin Zhang, and Runping Liu
January 2023, Frontiers in microbiology,
Jinzhao Bai, and Yajie Cai, and Zhiyan Huang, and Yiqing Gu, and Nana Huang, and Rong Sun, and Guimin Zhang, and Runping Liu
February 2021, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica,
Jinzhao Bai, and Yajie Cai, and Zhiyan Huang, and Yiqing Gu, and Nana Huang, and Rong Sun, and Guimin Zhang, and Runping Liu
February 2021, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica,
Jinzhao Bai, and Yajie Cai, and Zhiyan Huang, and Yiqing Gu, and Nana Huang, and Rong Sun, and Guimin Zhang, and Runping Liu
March 2024, Brain, behavior, and immunity,
Jinzhao Bai, and Yajie Cai, and Zhiyan Huang, and Yiqing Gu, and Nana Huang, and Rong Sun, and Guimin Zhang, and Runping Liu
February 2021, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica,
Jinzhao Bai, and Yajie Cai, and Zhiyan Huang, and Yiqing Gu, and Nana Huang, and Rong Sun, and Guimin Zhang, and Runping Liu
January 2024, Frontiers in microbiology,
Copied contents to your clipboard!